Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes
Authors:
- 1 September 2010
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (9) , 4180-4187
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Experimental Chemotherapy againstTrypanosoma cruziInfection Using Ruthenium Nitric Oxide DonorsAntimicrobial Agents and Chemotherapy, 2009
- Hydrolytic Reactivity Trends among Potential Prodrugs of the O2-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial ActivityJournal of Medicinal Chemistry, 2008
- Leishmaniasis treatment—a challenge that remains: a reviewParasitology Research, 2008
- The Giant Anteater in the Room: Brazil's Neglected Tropical Diseases ProblemPLOS Neglected Tropical Diseases, 2008
- In vitroandin vivoantiproliferative and trypanocidal activities of ruthenium NO donorsBritish Journal of Pharmacology, 2007
- New features in the redox coordination chemistry of metal nitrosyls {M–NO+; M–NO; M–NO−(HNO)}Coordination Chemistry Reviews, 2007
- The pharmacology of nitroxyl (HNO) and its therapeutic potential: Not just the janus face of NO11This review is dedicated to the career of Prof. Herbert T. Nagasawa, a pioneer in the field of HNO chemistry, biochemistry and pharmacology.Pharmacology & Therapeutics, 2007
- Ruthenium Tetraammines as a Model of Nitric Oxide Donor CompoundsEuropean Journal of Inorganic Chemistry, 2004
- Release of NO by a nitrosyl complex upon activation by the mitochondrial reducing powerJournal of Inorganic Biochemistry, 2002
- How do Protozoan Parasites Survive inside Macrophages?Parasitology Today, 1999